Statistics at a Glance
At a Glance
Estimated New Cases in 2023 64,050
% of All New Cancer Cases 3.3%
Estimated Deaths in 2023 50,550
% of All Cancer Deaths 8.3%
|Year||Rate of New Cases — SEER 8||Rate of New Cases — SEER 12||Death Rate — U.S.||5-Year Relative Survival — SEER 8|
|Observed||Modeled Trend||Observed||Modeled Trend||Observed||Modeled Trend||Observed||Modeled Trend|
New cases come from SEER 12. Deaths come from U.S. Mortality.
All Races, Both Sexes. Rates are Age-Adjusted.
Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software.
The 2020 incidence rate is displayed but not used in the fit of the trend line(s). Impact of COVID on SEER Cancer Incidence 2020 data
New cases are also referred to as incident cases in other publications. Rates of new cases are also referred to as incidence rates.
Rate of New Cases and Deaths per 100,000: The rate of new cases of pancreatic cancer was 13.3 per 100,000 men and women per year. The death rate was 11.1 per 100,000 men and women per year. These rates are age-adjusted and based on 2016–2020 cases and deaths.
Lifetime Risk of Developing Cancer: Approximately 1.7 percent of men and women will be diagnosed with pancreatic cancer at some point during their lifetime, based on 2017–2019 data.
Prevalence of This Cancer: In 2020, there were an estimated 95,389 people living with pancreatic cancer in the United States.
How Many People Survive 5 Years Or More after Being Diagnosed with Pancreatic Cancer?
Relative survival is an estimate of the percentage of patients who would be expected to survive the effects of their cancer. It excludes the risk of dying from other causes. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.
Based on data from SEER 22 (Excluding IL/MA) 2013–2019. Gray figures represent those who have died from pancreatic cancer. Green figures represent those who have survived 5 years or more.
Survival by Stage
Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. In general, if the cancer is found only in the part of the body where it started it is localized (sometimes referred to as stage 1). If it has spread to a different part of the body, the stage is regional or distant. The earlier pancreatic cancer is caught, the better chance a person has of surviving five years after being diagnosed. For pancreatic cancer, 12.9% are diagnosed at the local stage. The 5-year relative survival for localized pancreatic cancer is 44.3%.
|Stage||Percent of Cases||5-Year Relative Survival|
Confined to Primary Site
Spread to Regional Lymph Nodes
Cancer Has Metastasized
SEER 22 (Excluding IL/MA) 2013–2019, All Races, Both Sexes by SEER Combined Summary Stage
New Cases and Deaths
How Common Is This Cancer?
Compared to other cancers, pancreatic cancer is fairly common.
|Rank||Common Types of Cancer||Estimated New
|1.||Breast Cancer (Female)||297,790||43,170|
|3.||Lung and Bronchus Cancer||238,340||127,070|
|5.||Melanoma of the Skin||97,610||7,990|
|7.||Kidney and Renal Pelvis Cancer||81,800||14,890|
Pancreatic cancer represents 3.3% of all new cancer cases in the U.S.
In 2023, it is estimated that there will be 64,050 new cases of pancreatic cancer and an estimated 50,550 people will die of this disease.
Who Gets This Cancer?
Pancreatic cancer is more common with increasing age and slightly more common in men than women. The rate of new cases of pancreatic cancer was 13.3 per 100,000 men and women per year based on 2016–2020 cases, age-adjusted.
|Non-Hispanic American Indian/Alaska Native||16.5|
|Non-Hispanic Asian/Pacific Islander||10.9|
|Non-Hispanic American Indian/Alaska Native||11.0|
|Non-Hispanic Asian/Pacific Islander||9.2|
SEER 22 2016–2020, Age-Adjusted
|Age Range||Percent of New Cases|
Pancreatic cancer is most frequently diagnosed among people aged 65–74.
SEER 22 2016–2020, All Races, Both Sexes
Who Dies From This Cancer?
Because survival is poor, the population distribution of people who die of pancreatic cancer is similar to that of people who are diagnosed with the disease. In part because it is difficult to detect early, the average survival time from pancreatic cancer is low. Pancreatic cancer is the third leading cause of cancer death in the United States. The death rate was 11.1 per 100,000 men and women per year based on 2016–2020 deaths, age-adjusted.
|Non-Hispanic American Indian/Alaska Native||11.9|
|Non-Hispanic Asian/Pacific Islander||8.2|
|Non-Hispanic American Indian/Alaska Native||8.9|
|Non-Hispanic Asian/Pacific Islander||7.0|
U.S. 2016–2020, Age-Adjusted
|Age Range||Percent of Deaths|
The percent of pancreatic cancer deaths is highest among people aged 65–74.
U.S. 2016–2020, All Races, Both Sexes
Trends in Rates
Changes Over Time
Keeping track of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.
Using statistical models for analysis, age-adjusted rates for new pancreatic cancer cases have been rising on average 0.9% each year over 2010–2019. Age-adjusted death rates have been rising on average 0.1% each year over 2011–2020. 5-year relative survival trends are shown below.
Interactive Statistics with SEER*Explorer
- Create custom graphs and tables
- Download data and images
- Share links to results
SEER*Explorer is an interactive website that provides easy access to a wide range of SEER cancer statistics. It provides detailed statistics for a cancer site by gender, race, calendar year, age, and for a selected number of cancer sites, by stage and histology.Explore Additional Pancreatic Cancer Statistics
More About This Cancer
Cancer and the Pancreas
Figure: Anatomy diagram shows the pancreas, liver, bile duct, stomach, gallbladder, duodenum, spleen, colon, and small intestine.
The pancreas is an organ in the abdomen that helps the body digest and use the energy that comes from food. Pancreatic cancer occurs when cells in the pancreas grow out of control and form a growth or tumor. Tumors may be cancerous (malignant) or not cancerous (benign).
Here are some resources for learning more about pancreatic cancer.
- About risk factors for pancreatic cancer
- About symptoms and diagnosis of pancreatic cancer
- About treatment options for pancreatic cancer
- About clinical trials
- About cancer prevention
- About the health risks of smoking and ways to quit
All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within SEER*Explorer.
All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.
SEER Cancer Stat Facts: Pancreatic Cancer. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/pancreas.html
These stat facts focus on population statistics that are based on the U.S. population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse SEER*Explorer. To see statistics for a specific state, go to the State Cancer Profiles.
The statistics presented in these stat facts are based on the most recent data available, most of which can be found in SEER*Explorer. In some cases, different year spans may be used.
Estimates of new cases and deaths for 2023 are projections made by the American Cancer Society (ACS), based on earlier reported data.
Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.